New Product Launch at CellGenix
Preclinical Recombinant Human Interferon-gamma (rh IFN-γ)
CellGenix proudly announces the launch of E.coli derived Recombinant Human Interferon-gamma.
This new preclinical product will expand CellGenix’s product portfolio and can be used in several areas of application.
› E.coli derived; Human sequence
› High purity
› Thermostability up to 50°C as lyophilized product
› Batch specific Certificate of Analysis
› ADCF Level 2 (No ADC in product and production process)
Areas of Application
› Ex vivo maturation of dendritic cells (monocyte derived)
› Ex vivo generation of cytokine induced killer cells (CIK)
› Stimulation of monocytes, macrophages, and microglia
For preclinical ex vivo use. Not intended for therapeutic use.
From Research to ATMP - Your Dedicated Partner in Cell Therapy